Novo Nordisk gets landmark obesity pill approved, with production ‘underway' in NC [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
Novo Nordisk, Wegovy's maker, then confirmed where it will produce this new pill. “We are prepared for a full U.S. launch in early January 2026, with manufacturing well underway in our North Carolina facilities,” a company spokesperson told The News & Observer in an emailed statement Monday. In a separate statement, Novo Nordisk's vice president of U.S. operations Dave Moore said oral Wegovy's active ingredient, called semaglutide, will be made “from end-to-end in North Carolina.” Glucagon-like peptide-1, or GLP-1, lowers appetites by mimicking a natural hormone to prolong feelings of fullness and suppress appetites. They rose to prominence in the early 2020s as injectables, with millions of American taking them both on- and off-label to shed pounds. Novo Nordisk and Eli Lilly dominate the sector , with the former making Ozempic and Wegovy and the latter producing Mounjaro and Zepbound. The arrival of an oral GLP-1 specifically for weight loss is expected to alter this market,
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Medicare opens door to covering blockbuster drugs for weight loss [CNN]CNN
- Medicare opens door to covering blockbuster drugs for weight loss [CNN]CNN
- Lilly, Novo lock horns in India's obesity drug race [Yahoo! Finance]Yahoo! Finance
- Stock Market Today, Dec. 23: U.S. Stocks Hold Near Records on Narrow Tech-Led Gains [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk says FDA approved Wegovy pill to reduce body weight [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 11/6/25 - Beat
NVO
Sec Filings
- 12/23/25 - Form 6-K
- 11/25/25 - Form 6-K
- 11/24/25 - Form 6-K
- NVO's page on the SEC website